MHLD – RC – DECIPHERING BLACK BOX WARNINGS ON ANTIPSYCHOTIC MEDICATION

DECIPHERING BLACK BOX WARNINGS ON ANTIPSYCHOTIC MEDICATION

June 15, 2026 from 1:00 p.m. to 2:00 p.m.

Join speaker, John J. Miller, M.D., Medical Director, Brain Health, www.brain-health.co, Exeter, NH, Consulting Psychiatrist, Seacoast Mental Health Center, NH, Editor in Chief, Psychiatric Times (www.psychiatrictimes.com), Consulting Psychiatrist, Insight Meditation Society, Barre, MA and moderator, Essex County MHLD Regional Coordinator, Debra Dow, Esq.

Learning Objectives: You will learn about antipsychotic black box warnings and:

1. What are they and why do they matter?
2. Are they scientifically accurate/current?
3. What is “off label” use?
4. There will be a discussion of off label misuse awareness, such as the use of antipsychotic medication for management of behavioral symptoms, chemical restraints and for staff convenience
5. Are antipsychotic medications approved for use in elderly patients with dementia related psychosis?
6. What do the black box warnings say about increased risks of antipsychotics as they relate to mortality, cerebrovascular, and metabolic issues, such as diabetes and weight gain
7. What are the differences between black box warnings of typical v. atypical antipsychotic medications
8. Where to get the most up to date FDA black box warnings?
9. Practical advice to attorneys

1.0 Credit Available for all MHLD Litigation Attorneys

1.0 Additional Credit Available for MHLD Litigation Attorneys in Essex County who attend hour long Regional Coordinator Meeting after thetraining.

Click Here to Register for this Training